Allergy Peptide Array

Information

  • Research Project
  • 6785100
  • ApplicationId
    6785100
  • Core Project Number
    R43AI060122
  • Full Project Number
    1R43AI060122-01
  • Serial Number
    60122
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/15/2004 - 20 years ago
  • Project End Date
    3/14/2006 - 18 years ago
  • Program Officer Name
    HAMILTON, FRANK A
  • Budget Start Date
    3/15/2004 - 20 years ago
  • Budget End Date
    3/14/2006 - 18 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/8/2004 - 20 years ago
Organizations

Allergy Peptide Array

DESCRIPTION (provided by applicant): This proposal describes the application of a bead-based microarray platform for the rapid and simultaneous screening of multiple allergies. With increasing costs of medical care, rapid tests, which allow multiplexed screening of disease conditions in many samples simultaneously, will be invaluable. Allergies will be screened using the same basic immunoassay format currently employed in allergy testing. The innovation lies in adapting existing solid-phase immunoassay methods to the Sentrix/Tm BeadArray/Tm platform and in multiplexing and miniaturizing the assays. In the R21 Phase, using peanut allergy as a model system for proof of concept, peptide microarrays will be developed for screening peanut allergen-specific IgE binding, using known peanut allergen peptide epitopes. The peptide microarray development will avail of the available ability to sythesize large numbers of different peptides in a short time. Chemistry techniques for conjugating peptides with paired encoding oligonucleotides to beads have been deduced and will be further optimized. The plan for the R33 Phase of this project is to develop methodology on the Sentrix platform to screen multiple food allergies at the same time, including cow's milk, peanut, egg white and soy. Optimization of the multiplexed food allergies will be done to ensure quantitative assays with high reproducibility, precision and accuracy.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    169877
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:169877\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ILLUMINA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921211975
  • Organization District
    UNITED STATES